Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 8, 2026, 12:17 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1513–1536 of 6,755 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: CHANGE Study Clear all

Conditions: Glaucoma
Interventions: Prostaglandin Analogue -Containing IOP-Lowering Therapy, Beta Blocker, Brillouin Microscopy; Drug · Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Hyperopia, Farsightedness, Hypermetropia
Interventions: Experimental treatment arm; Combination Product
Lead sponsor: Ohio State University; Other
Eligibility: 13 Weeks to 19 Weeks
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Pediatric Cancer, Pediatric ALL, Pediatric Brain Tumor, Attention Difficulties, Cognitive Deficit in Attention
Interventions: EndeavorRx, Control video game; Device · Other
Lead sponsor: Children's National Research Institute; Other
Eligibility: 8 Years to 16 Years
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Washington D.C., District of Columbia

Conditions: HIV Positive, Alcohol Use
Interventions: Computerized Brief Intervention (CBI), CBT4CBT, Recommendation and Counseling for Alcohol Pharmacotherapy; Behavioral · Drug
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years and older
Enrollment: 4,985 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 2
States / cities: Birmingham, Alabama • Seattle, Washington

Conditions: Supine Hypotensive Syndrome, Cesarean Section Complications, Anesthesia Complication
Interventions: Blood Pressure Cuff; Other
Lead sponsor: Ohio State University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Breast Cancer, Obesity, Weight Changes
Interventions: Diet, Spiritual counseling; Behavioral · Other
Lead sponsor: Barbara Ann Karmanos Cancer Institute; Other
Eligibility: 18 Years to 70 Years · Female only
Enrollment: 31 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2008
U.S. locations: 1
States / cities: Detroit, Michigan

Conditions: Tobacco Smoking Behavior, Cigarette Smoking Behavior, Second Hand Tobacco Smoke, Tobacco Use Cessation
Interventions: Personalized Feedback; Behavioral
Lead sponsor: University of Oklahoma; Other
Eligibility: 18 Years to 65 Years
Enrollment: 152 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Mild Traumatic Brain Injury
Interventions: MRI imaging exam; Device
Lead sponsor: The Geneva Foundation; Other
Eligibility: 18 Years to 55 Years
Enrollment: 160 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2026
U.S. locations: 2
States / cities: Bethesda, Maryland • Fort Belvoir, Virginia

Conditions: Pediatric Obesity
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 10 Years to 18 Years
Enrollment: 295 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Sarcoma,Soft Tissue, Sarcoma Uterus
Interventions: Niraparib; Drug
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 7
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more

Conditions: Esophageal Adenocarcinoma
Interventions: FOLFOX (5-fluorouracil, Leucovorin, Oxaliplatin); Drug
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2034
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Proportional Reasoning
Interventions: Verbal Interference Task; Behavioral
Lead sponsor: Michelle Hurst, PhD; Other
Eligibility: 7 Years to 64 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Piscataway, New Jersey

Conditions: Youths At-risk for Drug Use/Abuse
Interventions: Integrated Family and Cognitive-Behavioral Drug Prevention Intervention, Psychoeducation; Behavioral · Other
Lead sponsor: University of Florida; Other
Eligibility: 11 Years to 15 Years
Enrollment: 330 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2011
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Prostate Cancer
Interventions: AAA817, ARPI, Standard of Care; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years to 100 Years · Male only
Enrollment: 940 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2032
U.S. locations: 42
States / cities: Homewood, Alabama • Tucson, Arizona • Orange, California + 37 more

Conditions: Hodgkin Lymphoma
Interventions: bendamustine, Etoposide, Doxorubicin, Bleomycin, Vincristine, Vinblastine, Prednisone, Filgrastim, Brentuximab Vedotin, Cyclophosphamide, DTIC, Quality of Life Measurements, Radiotherapy; Drug · Other · Radiation
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Up to 25 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2028
U.S. locations: 8
States / cities: Palo Alto, California • Peoria, Illinois • Baton Rouge, Louisiana + 4 more

Conditions: Hematopoietic Stem Cell Transplantation, Cancer
Interventions: care.coach Avatar™; Behavioral
Lead sponsor: Victor Wang; Industry
Eligibility: 19 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Kidney Disease (CKD)
Interventions: CKD Registry, ATSM + Health Coach, Usual care; Behavioral
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years to 75 Years
Enrollment: 375 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2020
U.S. locations: 2
States / cities: San Francisco, California

Conditions: Musculoskeletal Injury
Interventions: Self-Directed Exercise Program, Clinic-Based Physical; Behavioral
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years to 65 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 2
States / cities: Charlotte, North Carolina • Greenville, South Carolina

Conditions: Locally Advanced Solid Tumor, Metastatic Solid Tumor
Interventions: NVL-330; Drug
Lead sponsor: Nuvalent Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 17
States / cities: Irvine, California • Sacramento, California • Stanford, California + 13 more

Conditions: Intestinal Health
Interventions: "Humanized" galacto-oligosaccharides (hGOS), Galacto-oligosaccharides (GOS), Matching Placebo; Dietary Supplement · Other
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years to 55 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Metastatic Hormone-sensitive Prostate Cancer
Interventions: JSB462, Abiraterone, Enzalutamide; Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 168 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2035
U.S. locations: 21
States / cities: La Jolla, California • Santa Monica, California • Denver, Colorado + 18 more

Conditions: PTSD, AUD
Interventions: COPE + BFIT; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2031
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Carcinoma, Metastatic Pancreatic Adenocarcinoma
Interventions: Oleclumab, Durvalumab, Gemcitabine, Nab-paclitaxel, Oxaliplatin, Folinic acid, 5-FU; Drug
Lead sponsor: MedImmune LLC; Industry
Eligibility: 18 Years to 101 Years
Enrollment: 213 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 18
States / cities: La Jolla, California • Aurora, Colorado • Fort Myers, Florida + 14 more

Conditions: Rectal Cancer
Interventions: Radiation, Aflibercept, Surgery, FOLFOX6; Radiation · Drug · Procedure
Lead sponsor: SCRI Development Innovations, LLC; Other
Eligibility: 18 Years and older
Enrollment: 39 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 11
States / cities: Fort Myers, Florida • Pensacola, Florida • St. Petersburg, Florida + 8 more

Search by objective public record fields.

Study of Corneal Biomechanics in Glaucoma Patients Using Brillouin Microscopy

The Emmetropization Via Accommodation (EVA) - II Study

Feasibility/Acceptability of Attentional-Control Training in Survivors

Alcohol Research Consortium in HIV-Intervention Research Arm

Arm and Ankle Blood Pressure Cuffs During C-Section

Weight Loss Counseling for African American Women Who Are Breast Cancer Survivors

OCAST Cessation Study

Acute and Mild TBI Injury in Military and Civilian Population Using Advanced MR Imaging

Pediatric Obesity Observational Prospective Trial

A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA

Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma

Modifying Cognitive Strategies for Comparing Proportions

Neurological Influences on Drug Prevention Intervention

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Pediatric Classical Hodgkin Lymphoma Consortium Study: cHOD17

Supportive Care Intervention for Outpatient Stem Cell Transplant Patients

Kidney Awareness Registry and Education

Use of a Self-Directed Exercise Program (SDEP) Following Selected Lower Extremity Fractures

A Study of NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Safety, Tolerability, and Biosignature of Humanized Prebiotics in Healthy Adults

An Open-label Study of JSB462 (Luxdegalutamide) in Combination With Abiraterone in Adult Male Patients With Metastatic Hormone-sensitive Prostate Cancer (mHSPC)

PTSD and Alcohol Couples Treatment for Veterans

MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study.

5-FU, Aflibercept, and Radiation (RT) for Preoperative and Postoperative Patients With Stage II/III Rectal Cancer